Instanosis Inc. Instanosis enables rapid and portable detection and quantitation of extremely low concentrations of biomarkers across many diseases using simple smartphone and advanced data algorithms. This first-of-its-kind technology is hundreds of times more sensitive than state-of-the-art, at much lower cost, leading to accurate and instantly actionable results and cost savings for research, clinical trials, disease diagnosis and monitoring

The technology is based on proprietary technology developed out of the Founder’s laboratory at Penn. This platform has many applications in Infectious Diseases, Cardiology, Neurology and other disease areas, where rapid, convenient and ultra-sensitive biomarker detection is crucial for disease detection and treatment.

Startup Details

Founded by:

Looking for: Partnerships, Seed Investment, Management

Contact: Jeffrey James

Reference Dockets # 18-859420-9363

Skip to content